Magda Marquet

Magda Marquet is recorded as Board Member at Immix Biopharma, Inc. (IMMX), Board Member at Anaptysbio, Inc (ANAB) since March 27, 2026 and Board Member at Transcode Therapeutics, Inc. (RNAZ) since January 1, 2021. The newest filing on record that lists Magda Marquet as Board Member at Immix Biopharma, Inc. (IMMX) is dated April 6, 2026. The newest filing on record that lists Magda Marquet as Board Member at Transcode Therapeutics, Inc. (RNAZ) is dated June 2, 2026. Anaptysbio, Inc reported in an 8-K filed April 20, 2026 that Magda Marquet resigned as board of directors of the Company, effective April 20, 2026. Anaptysbio, Inc reported in an 8-K filed March 27, 2026 that Magda Marquet was appointed Board of Directors. Transcode Therapeutics, Inc. reported in an 8-K filed December 22, 2025 that Magda Marquet resigned as member of the Audit Committee of the Board, effective December 19, 2025. Equibles holds 4 filed executive changes naming Magda Marquet; each is listed under recent activity with its source filing. Anaptysbio, Inc is classified in the Biotechnology industry within the Healthcare sector. Immix Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Anaptysbio, Inc includes Daniel Faga (CEO and Board Member), John Orwin (Chairman and Board Member), Ajim Tamboli (CFO) and 7 others.